BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| 2-Methyl-5-(1-methylethyl)phenol {Carvacrol} - Campylobacter |
👪
Therapeutic Oral Application of Carvacrol Alleviates Acute Campylobacteriosis in Mice Harboring a Human Gut Microbiota. Biomolecules (Biomolecules ) Vol: 13 Issue 2 Pages: Pub: 2023 Feb 8 Epub: 2023 Feb 8 Authors Foote MS , Du K , Mousavi S , Bereswill S , Heimesaat MM , Html Article Publication |
| 2-Methyl-5-(1-methylethyl)phenol {Carvacrol} - Campylobacter |
👪
Carvacrol attenuates Campylobacter jejuni colonization factors and proteome critical for persistence in the chicken gut. Poultry science (Poult Sci ) Vol: 99 Issue 9 Pages: 4566-4577 Pub: 2020 Sep Epub: 2020 Jul 2 Authors Wagle BR , Donoghue AM , Shrestha S , Upadhyaya I , Arsi K , Gupta A , Liyanage R , Rath NC , Donoghue DJ , Upadhyay A , Html Article Publication |
| 2-Methyl-5-(1-methylethyl)phenol {Carvacrol} - Campylobacter |
👪
Carvacrol ameliorates acute campylobacteriosis in a clinical murine infection model. Gut pathogens (Gut Pathog ) Vol: 12 Issue Pages: 2 Pub: 2020 Epub: 2020 Jan 8 Authors Mousavi S , Schmidt AM , Escher U , Kittler S , Kehrenberg C , Thunhorst E , Bereswill S , Heimesaat MM , Html Article Publication |
| 2-Methyl-5-(1-methylethyl)phenol {Carvacrol} - Campylobacter |
👪
Carvacrol prophylaxis improves clinical outcome and dampens apoptotic and pro-inflammatory immune responses upon Campylobacter jejuni infection of human microbiota-associated IL-10-/- mice. European journal of microbiology & immunology (Eur J Microbiol Immunol (Bp) ) Vol: 14 Issue 2 Pages: 166-179 Pub: 2024 May 14 Epub: 2024 Mar 11 Authors Heimesaat MM , Langfeld LQ , Schabbel N , Mousavi S , Bereswill S , Html Article Publication |
| 2-Methyl-5-(1-methylethyl)phenol {Carvacrol} - Campylobacter |
📓
Carvacrol attenuated lipopolysaccharide-induced intestinal injury by down-regulating TLRs gene expression and regulating the gut microbiota in rabbit. Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 11447 Pub: 2023 Jul 15 Epub: 2023 Jul 15 Authors Wu D , Xia M , Yan A , Jiang H , Fan J , Zhou S , Wei X , Liu S , Chen B , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
